[HTML][HTML] Unified Methodology for the Primary Preclinical In Vivo Screening of New Anticoagulant Pharmaceutical Agents from Hematophagous Organisms
MA Kostromina, EA Tukhovskaya… - International Journal of …, 2024 - mdpi.com
The development of novel anticoagulants requires a comprehensive investigational
approach that is capable of characterizing different aspects of antithrombotic activity. The …
approach that is capable of characterizing different aspects of antithrombotic activity. The …
[引用][C] Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we still debating?
M Cohen, S Sohal - Cardiovascular Revascularization Medicine …, 2023 - europepmc.org
Editorial: Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we
still debating? - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
still debating? - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …